David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
After a strong run, it’s typical to see a stock chart start to flatten out as buyers and sellers move into equilibrium. More often than not, that’s a sign to take profits. Not only do fundamental measures often tell you that a stock is fairly valued at this point, but… Read More
The medical device sector is still reeling from the healthcare reform bill. Slapped with a 3% tax increase effective January 2013, many medical device manufacturers and distributors such as Medtronics (NYSE: MDT) and Stryker (NYSE: SYK) fear future sales and earnings… Read More
What do penguins in Antarctica and a company in Colorado have to do with the profits you can make on the New York Stock Exchange? More than you might think. Antarctica’s clusters of emperor penguins are spread across the 5.4 million square miles of… Read More
How many times have you walked through the aisles of your local grocery store and mindlessly grabbed items off the shelf that are staples of your home? Things like spaghetti sauce, dish soap, shampoo, paper towels… the little necessities life requires. How many times have you plucked… Read More
As European countries step up in support of Greece (and by extension the banks who are lending to that troubled country), it should come as no surprise that major European bank stocks are posting strong gains in Monday trading. Shares of Netherlands-based ING (NYSE:… Read More
Today’s market action is a rising tide that is lifting all boats. Well, almost all of them. Dean Foods (NYSE: DF), which makes a wide range of products found in the dairy section of supermarkets, hit a 52-week low after announcing that pricing pressures are forcing… Read More
How low can you go? That’s the question many investors are asking about China Security & Surveillance Technology (NYSE: CSR). Shares keep on dropping, and the forward P/E ratio, which had been a paltry six, then drifted to… Read More
The ramifications of the credit crisis in the insurance industry are still being determined as regulators throughout the globe are scrambling to settle on the appropriate capital levels and financial cushions these firms must satisfy to stave off a future calamity. But despite the worries, conditions are quickly returning to… Read More
Shares of Crocs (Nasdaq: CROX) continued their remarkable rebound, only a year after many had assumed that the once-hot footwear maker would not survive much longer. An impressive quarterly report released Thursday evening pushed shares up +8% in Friday trading. Crocs’ plastic shoes… Read More
Throughout much of the last decade, Hansen Natural (Nasdaq: HANS) dominated the lists of potential buyout candidates. The beverage maker was seeing tremendous demand for its various juices and sodas, especially its Monster energy drink, right at a time when the largest beverage… Read More
